
Sudeep Pharma Ltd. (SUDEEPPHRM): Sudeep Pharma Share Price hits fresh 52-week high; stock rises 3.87% to Rs 1,257.20
Updated: 1 Sept 2026 • 9:46 am
Posted by:

Sudeep Pharma Share Price is in focus after Sudeep Pharma Ltd. (SUDEEPPHRM) rose 3.87% to Rs 1,257.20 and touched a fresh 52-week high of Rs 1,264.25. The company’s market capitalisation stands at Rs 13,020.15 Cr, placing the update among the more closely tracked Healthcare stock moves in Indian Stock Market trade today. The supplied data confirms the price event and shows the stock has moved through its yearly high zone, but it does not establish a company-specific catalyst. For readers following Sudeep Pharma Share Price Today, the key facts are the day’s range, the higher close relative to the previous session and the fresh 52-week peak that has placed the stock in Sudeep Pharma Stock News flows.
The move also matters because the price is trading above the previous close of Rs 1,210.35 and finished near the day’s high after opening at Rs 1,175.45 and printing a low of Rs 1,175.45. In Univest coverage, Sudeep Pharma Share Price news is best read as an event-led update: the verified market data explains what happened, while the supplied fundamentals, sector metrics and peer comparisons help frame how the market is valuing the company. Sudeep Pharma Share Price Today therefore combines a fresh 52-week high with valuation, profitability and sector context rather than a stated reason for the move.
Sudeep Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,257.2 |
| Previous Close | Rs 1,210.35 |
| Today's Move | +Rs 46.85 (+3.87%) |
| Open | Rs 1,175.45 |
| High | Rs 1,264.25 |
| Low | Rs 1,175.45 |
| Turnover | Rs 1.05 crore |
| Market Capitalisation | Rs 13,020.15 crore |
Sudeep Pharma Ltd. (SUDEEPPHRM) traded at Rs 1,257.2 versus the previous close of Rs 1,210.35, a rise of 3.87%. The stock opened at Rs 1,175.45, reached a high of Rs 1,264.25 and touched a low of Rs 1,175.45.
Sudeep Pharma Share Price Today shows a clear upward session in which Rs 1,257.20 was the last price, Rs 46.85 above the previous close of Rs 1,210.35. The stock opened at Rs 1,175.45, matched that level as the day low, and reached Rs 1,264.25 as the day high, which is also the fresh 52-week high. That means the stock ended the day close to its peak print after a session range of Rs 88.80. Turnover for the day stood at Rs 1.05 Cr, and the day’s action was strong enough to place Sudeep Pharma Ltd. firmly in 52 Week High Stocks and Stocks in News searches without requiring any unstated reason.
The gap between the previous close and the fresh peak is Rs 53.90, which is a 4.46% move from the prior high reference. For Sudeep Pharma Share Price, the verified numbers are more important than assumptions: the stock has moved to a one-year high, the session range was wide, and the close held well above the prior session. That is the relevant price action story in Sudeep Pharma Share News and Sudeep Pharma Latest News today. Investors tracking Sudeep Pharma Share Price Live can use this session as the latest reference point before reviewing the company’s financial quality and valuation context. That naturally leads into the fundamental picture and the broader Sudeep Pharma Stock Analysis narrative.
Sudeep Pharma Ltd. (SUDEEPPHRM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 13,020.15 crore |
| P/E Ratio | 74.85x |
| P/B Ratio | 14.8x |
| ROE | 25.37% |
| ROCE | 28.5% |
| EPS | Rs 16.17 |
| Book Value Per Share | Rs 81.8 |
| Dividend Yield | 0.12% |
Sudeep Pharma Ltd. (SUDEEPPHRM) fundamental metrics show P/E 74.85x, P/B 14.8x, ROE 25.37%, ROCE 28.5%. These figures provide context only and are not a buy or sell signal.
Sudeep Pharma Ltd. has a market capitalisation of Rs 13020.15 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 74.85x, P/B at 14.8x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 25.37% and ROCE of 28.5%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 16.17, book value per share of Rs 81.8, dividend yield of 0.12%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.86x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 74.85x |
| Benchmark Median P/E | 30.86x |
| Benchmark Average P/E | 47.86x |
| Benchmark P/E Range | 3.87x to 667.16x |
| Company P/B Ratio | 14.8x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 25.37% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 28.5% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 13,020.15 crore |
| Benchmark Median Market Cap | Rs 679.12 crore |
Sudeep Pharma Ltd. (SUDEEPPHRM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 74.85x, which is above the benchmark median of 30.86x, a difference of +142.55%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROE of 25.37%, which is above the benchmark median of 11.79%, a difference of +115.18%. Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROCE of 28.5%, which is above the benchmark median of 13.63%, a difference of +109.1%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| CORONA Remedies Ltd. | CORONA | 12,739.95 | 62.93 | 15.52 | 27.36 | 31.74 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | 12,158.69 | 41.91 | 3.58 | 8.06 | 14.77 |
| Jubilant Pharmova Ltd. | JUBLPHARMA | 14,049.39 | 39.92 | 1.97 | 5.97 | 8.69 |
| Sequent Scientific Ltd. | VIYASH | 11,756.53 | 67.79 | 4.13 | 9.06 | 13.1 |
| Marksans Pharma Ltd. | MARKSANS | 14,931.75 | 28.32 | 4.6 | 15.31 | 21.1 |
Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 74.85x compared with the displayed peer median of 41.91x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 25.37% compares with a peer median of 9.06% across the companies shown in the table. ROCE stood at 28.5% versus the displayed peer median of 14.77%, providing a capital-efficiency comparison. Sudeep Pharma Ltd. (SUDEEPPHRM) has a market capitalisation of Rs 13,020.15 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Sudeep Pharma
- Sudeep Pharma Share Price rose 3.87% to Rs 1,257.20 and touched a fresh 52-week high of Rs 1,264.25.
- The stock’s day range was Rs 1,175.45 to Rs 1,264.25, with turnover of Rs 1.05 Cr.
- The market capitalisation is Rs 13,020.15 Cr, and the company is in Healthcare and Pharmaceuticals & Drugs.
- Key fundamentals include P/E of 74.85, P/B of 14.8, ROE of 25.37%, ROCE of 28.5%, EPS of 16.17 and book value of Rs 81.8.
- In the supplied industry benchmark, company P/E, P/B, ROE and ROCE all sit above the median reference points.
About Sudeep Pharma
Sudeep Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For Sudeep Pharma Share Price readers, the most relevant company facts in this update are the sector classification, the financial metrics, and the market capitalisation. The supplied data positions the company inside a broad healthcare peer set on Univest, with valuation and profitability figures forming the core of the current Sudeep Pharma Stock Analysis narrative. Sudeep Pharma Share Price Today is therefore best understood through the company’s reported financial ratios and benchmark comparisons rather than unsupported business assumptions.
Track Sudeep Pharma Share Price on Univest
Use Sudeep Pharma Ltd. (SUDEEPPHRM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Sudeep Pharma Share Price on Univest for live share price updates, 52-week levels, fundamental ratios, shareholding pattern, market insights and sector comparisons. Univest keeps Sudeep Pharma Share Price Today aligned with the latest verified market data and Sudeep Pharma Stock News coverage.
Conclusion: Sudeep Pharma Share Price has moved to a fresh 52-week high, and the supplied data points to a session defined by price action, valuation and sector comparison. For readers following Sudeep Pharma Share Price Today, Univest will continue to track the stock’s market cap, fundamentals and relative positioning in Healthcare.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Sudeep Pharma Share Price hit a fresh 52-week high?
Ans. The supplied market data confirms that Sudeep Pharma Share Price touched Rs 1,264.25, a fresh 52-week high, but it does not establish a company-specific catalyst. The move is visible in the day’s price action and close.
What is the current Sudeep Pharma Share Price?
Ans. The current Sudeep Pharma Share Price is Rs 1,257.20. It is above the previous close of Rs 1,210.35 and sits just below the day’s high of Rs 1,264.25, which is also the fresh yearly peak.
How much did Sudeep Pharma Share Price rise today?
Ans. Sudeep Pharma Share Price rose Rs 46.85, or 3.87%, in the latest session. The stock opened at Rs 1,175.45, touched Rs 1,264.25, and finished at Rs 1,257.20. The stock moved 3.87% during the session.
What is the market capitalisation of Sudeep Pharma?
Ans. Sudeep Pharma has a market capitalisation of Rs 13,020.15 Cr. That places it well above the industry median market cap of Rs 679.12 Cr and close to the same-industry average benchmark.
What does the 52-week high mean for Sudeep Pharma Share Price?
Ans. The 52-week high marks the highest price seen in the past year. For Sudeep Pharma Share Price, that level is Rs 1,264.25, and the latest close shows the stock holding near that peak.
How expensive is Sudeep Pharma compared with sector benchmarks?
Ans. Sudeep Pharma’s P/E of 74.85 is above the industry median of 30.86 and average of 47.86. Its P/B of 14.8 is also above the benchmark median of 2.88 and average of 4.29.
What do ROE and ROCE show in Sudeep Pharma Share Price analysis?
Ans. ROE is 25.37% and ROCE is 28.5%. Both are above the sector median references of 11.79% and 13.63%, which gives Sudeep Pharma Share Price a strong profitability context. The stock moved 3.87% during the session.
What are the EPS and book value for Sudeep Pharma?
Ans. EPS is 16.17 and book value is Rs 81.8 per share. These figures help frame the current Sudeep Pharma Share Price against earnings per share and accounting net worth per share.
What is the dividend yield for Sudeep Pharma Share Price?
Ans. The dividend yield is 0.12%. It is a factual income metric for Sudeep Pharma Share Price, and it should be read alongside the company’s valuation and profitability figures rather than in isolation.
Where can investors track Sudeep Pharma Share Price today?
Ans. Investors can track Sudeep Pharma Share Price on Univest for live updates, 52-week levels, valuation ratios, shareholding pattern and sector comparisons. The platform consolidates the latest verified market data in one place.
Recent Articles

Augmont Enterprises Ltd. (AUGMONT) Share Price Falls to Fresh 52-Week Low
1 September 2026

Tempsens Instruments (India) Ltd. (TEMPSENS) Share Price Hits Fresh 52-Week Low
1 September 2026

Vadilal Enterprises Ltd. (VADILENT) Share Price Rises 11.08% Today
1 September 2026

EPL (EPL) Share Price Falls 5.39% Today; What the Decline Signals
1 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Augmont Enterprises Ltd. (AUGMONT) Share Price Falls to Fresh 52-Week Low
Tempsens Instruments (India) Ltd. (TEMPSENS) Share Price Hits Fresh 52-Week Low
Vadilal Enterprises Ltd. (VADILENT) Share Price Rises 11.08% Today
EPL (EPL) Share Price Falls 5.39% Today; What the Decline Signals
Nifty 50 Today: Opening Bell Market Update, 1 September 2026
Popular this week
RBZ Jewellers Ltd. (RBZJEWEL): RBZ Jewellers Share Price Rises 18.23% Today; What the Move Means

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





